vTv Therapeutics Inc. Gains 100.6%
Wed, Feb 28, 2024 at 07:11 PM
vTv Therapeutics Inc. (VTVT:NASDAQ) shot up at $16.65, representing a gain of 100.6%. On Wed, Feb 28, 2024, VTVT:NASDAQ touched a New 2-Week High of $16.65. The stock appeared on our News Catalysts scanner on Wed, Feb 28, 2024 at 10:26 AM in the 'PRIVATE PLACEMENT' category. From Wed, Feb 14, 2024, the stock recorded 44.44% Up Days and 20.00% Green Days
The stock spiked on Wed, Feb 28, 2024 at $23.5 with a volume of 3M+.
About vTv Therapeutics Inc. (VTVT:NASDAQ)
vTv Therapeutics Inc is a biopharmaceutical company engaged in drug discovery and development. Its therapies are intended to treat diseases such as Alzheimer's and type-II diabetes.
Top 10 Gainers:
- Vivani Medical Inc. Com (VANI:NASDAQ), 270.3%
- Envoy Med Inc Cl A (COCH:NASDAQ), 190.08%
- Sizzle Acquisition Corp. (SZZL:NASDAQ), 125.23%
- vTv Therapeutics Inc. (VTVT:NASDAQ), 100.6%
- Adial Pharmaceuticals, Inc. (ADIL:NASDAQ), 91.33%
- Movella Holdings Inc Com (MVLA:NASDAQ), 61.29%
- Bandwidth Inc. (BAND:NASDAQ), 51.77%
- Incannex Healthcare Limited (IXHL:NASDAQ), 48.58%
- ASLAN Pharmaceuticals Limited (ASLN:NASDAQ), 46.44%
- ACM Research, Inc. (ACMR:NASDAQ), 40.8%